MFIM
SPHS

Mesirow Financial Investment Management’s Sophiris Bio, Inc. SPHS Stock Holding History

Mesirow Financial Investment Management’s Portfolio SPHS Stock Details SPHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-54,510
Closed -$120K – 66
2017
Q2 		$120K Buy
+54,510
New +$134K 0.57% 54

Other funds holding SPHS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return

Mesirow Financial Investment Management's SPHS Position: Q3 2017 in Review

Mesirow Financial Investment Management sold out of Sophiris Bio, Inc. (SPHS) in Q3 2017, closing a stake of 54,510 shares — an estimated $120K sold.

Mesirow Financial Investment Management first reported a position in SPHS in Q2 2017 and held it in 1 quarter. The position peaked at $120K in Q2 2017. 25 funds tracked by Wall St. Rank hold SPHS as of Q3 2017.

  • Mesirow Financial Investment Management reported no remaining Sophiris Bio, Inc. position as of Q3 2017 after selling out during the quarter.
  • Mesirow Financial Investment Management sold 54,510 Sophiris Bio, Inc. shares in Q3 2017, an estimated $120K.
  • Mesirow Financial Investment Management first reported a position in Sophiris Bio, Inc. in Q2 2017 and held it in 1 quarter.
  • Mesirow Financial Investment Management's Sophiris Bio, Inc. position peaked at $120K in Q2 2017.
  • 25 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q3 2017.

Based on Mesirow Financial Investment Management's 13F filing for Q3 2017, filed 12 Oct 2017.